Mumbai, India

Horst Dornauer

This inventor holds 9 USPTO granted patents. Top assignees: Hoechst Aktiengesellschaft, American Hoechst Corporation. Active years: 1978-1986.


% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 111(Granted Patents)


Location History:

  • Bombay, IN (1978 - 1986)
  • Kelkheim, DE (1981 - 1986)

Company Filing History:


Years Active: 1978-1986

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Horst Dornauer: Innovator in Pharmaceutical Compounds

Introduction

Horst Dornauer is a notable inventor based in Bombay, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of 9 patents to his name, Dornauer's work has had a considerable impact on medical science.

Latest Patents

Dornauer's latest patents include innovative compounds such as pyrimido(6-1-a)isoquinolin-4-one derivatives. These compounds are disclosed as useful hypotensive agents, bronchodilators, and anti-allergenics. Additionally, he has developed 9,10-substituted-2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2H-pyrimido-(6,1-a)isoquinoline-4-ones and their salts, which exhibit hypotensive and vasodilating properties. His research focuses on the preparation methods for these compounds and intermediates.

Career Highlights

Throughout his career, Dornauer has worked with prominent companies such as Hoechst Aktiengesellschaft and American Hoechst Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovation and development.

Collaborations

Dornauer has collaborated with notable colleagues, including Noel J De Souza and Alihussein N Dohadwalla. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Horst Dornauer's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents that benefit medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…